Comparative Validation of PlusoptiX and AI-Optic Photoscreeners in Children with High Amblyopia Risk Factor Prevalence.

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

Plusoptix provided more valid amblyopia and refractive screening than the cheaper AI Optic. Clinics must weigh cost versus performance, and central data sharing before selecting one of these vision-saving devices.

Keyphrases

risk factors
artificial intelligence
optical coherence tomography
optic nerve
big data
primary care
young adults
electronic health record
social media
health information
machine learning
data analysis